Oct 17, 2018
American Brain Tumor Association Launches 2018 Request for Grant Applications to Continue Driving Advances in the Brain Tumor Field
Oct 10, 2018
DelMar Announces Further Validation of the Mechanism of Action of VAL-083
Sep 10, 2018
Barrow Receives Largest Grant in History To Seek Cure for Deadly Brain Cancer
Aug 21, 2018
IDH "Encyclopedic" Research Review Debuts in Academic Journal, Cancer Cell
Jul 25, 2018
Tolero Pharmaceuticals Announces First Patient Dosed with Investigational Agent TP-0184, an Activin A Receptor Type 1 (ACVR1) Inhibitor, in Phase 1 Study of Patients with Advanced Solid Tumors
Jul 09, 2018
San Diego Gamma Knife Center: Diagnostic Precision Leads to Treatment Precision for Primary Brain Gliomas
May 22, 2018
New Published Evidence for Deadly High-Grade Gliomas Linked to Improved Survival
Apr 30, 2018
NX Development Corp (NXDC) Announces Merger Acquisition by photonamic GmbH & Co. KG, a German Biotech Firm Engaged in 5-ALA-Related Pharmaceutical Business in Europe
Apr 17, 2018
DelMar Pharmaceuticals Presents Positive Updates on Two Ongoing Clinical Trials with VAL-083 for Treatment of MGMT-unmethylated GBM
Feb 14, 2018
Scientists Find a Pathway That Leads to Resistance of Aggressive Brain Tumor Treatment
Dec 07, 2017
Alcyone Lifesciences Announces First Pediatric Patient Treated with AMC for Treatment of DIPG
Dec 05, 2017
DNAtrix Announces First Pediatric Patient Treated with Oncolytic Virus DNX-2401
Nov 21, 2017
DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting
Oct 27, 2017
Tocagen Presents Updated Durable Complete Response Data from Phase 1 Trial of Toca 511 & Toca FC in Recurrent High-Grade Glioma
Sep 11, 2017
DelMar Pharmaceuticals Initiates Phase 2 Clinical Trial in Newly Diagnosed MGMT-unmethylated Glioblastoma Multiforme
Aug 22, 2017
Brain Tumor Diagnosis and Treatments Market to Reach U.S.$840.7 Million by 2025; Technological Advancements Augur Well for Future
Aug 15, 2017
Children's National part of pediatric cancer research collective awarded millions by NIH
Aug 01, 2017
ABTA Awards 18 Research Grants to Support Early Career Investigators and High-Impact, Collaborative Brain Tumor Research
Jul 25, 2017
Creative Medical Technology Holdings Demonstrates AmnioStem Derived Exosomes Inhibit Glioma Growth
Jul 24, 2017
Tocagen Receives European Medicines Agency Priority Medicines (PRIME) Designation for Toca 511 in High Grade Glioma